Research Report on China's Ophthalmic Preparation Industry 2011-2012

50pages

Published Date: April 2011

Published By: China Research and Intelligence Co., Ltd. (CRI)
Description


In China, ophthalmic diseases mainly include cataract, glaucoma, ocular inflammations, xeroma, ocular fundus diseases, ocular trauma, PCO (posterior capsule opacification), etc., among which cataract and glaucoma rank the first two in terms of prevalence of ophthalmic diseases. 

In China, ophthalmic preparations are mainly divided in such five categories as pharmaceutical chemicals, Chinese patent medicines, health products, disinfection sterilization products and apparatus.

In 2010, China's ophthalmic preparation market realized about CNY 6.90 billion, increasing by about 8.20% YOY.

After years of development, China's retail market of ophthalmic products has formed such five medicine categories as visual fatigue relieving medicines, anti-inflammatory medicines, cataract relieving medicines, pseudo myopia medicines and anti-glaucoma medicines, among which visual fatigue relieving medicines occupy the largest market share of over 30%; anti-inflammatory medicines are closely followed, accounting for about 30% of the market share; cataract medicines and pseudo myopia medicines occupy over 10% of the market share while anti-glaucoma medicines occupy a relatively small share of only 1%.

It can be found from the research on sales of the ophthalmic preparation market by preparation formulations that eye drops occupy the largest market share, reaching over 80% of the whole ophthalmic preparation market. In fact, convenience and quick results of eye drops are favored by consumers, and most consumers have formed the preference for eye drop preparation formulation. This situation will not change in the short run. Therefore, the leading position of eye drop preparation will be firm and stable in the market.

In China's ophthalmic preparation market, Shandong Chia Tai Freda Pharmaceutical and Mentholatum (Zhongshan) Pharmaceutical Co., Ltd. rank among the first group. Japan Santen Pharmaceutical Co., Ltd. and Jiangxi Tianshikang Traditional Chinese Medicine Co., Ltd. rank among the second group.

With gradual aging of the Chinese population, intensified environmental pollution and popularity of computers, the incidence of ophthalmic diseases in China keeps rising. It is predicted that in the next few years, China's annual growth rate of the ophthalmic market will remain above 8%. 

As for ophthalmic preparation manufacturers, the status of Chinese market will become increasingly important.

More following information can be acquired from this report:

  • Status of China's Ophthalmic Preparation Market
  • Competition in China's Ophthalmic Preparation Market
  • China's Major Ophthalmic Preparation Manufacturers
  • Development Trend of China's Ophthalmic Preparation Industry

Following are suggested to buy this report:

  • Ophthalmic Preparation Manufacturers
  • Ophthalmic Preparation Trading Enterprises
  • Investors Focusing on Ophthalmic Preparation Industry
  • Investors Focusing on Ophthalmic Preparation Industry

 

 

Table of Content

1 Ophthalmic Preparation Overview
1.1 Ophthalmic Disease Overview
1.1.1 Cataract
1.1.2 Glaucoma
1.1.3 Ocular Inflammations
1.1.4 Xeroma
1.1.5 Ocular Fundus Diseases
1.2 Incidence of Ophthalmic Diseases in China

2 Status of China's Ophthalmic Preparation Market, 2009-2010
2.1 Analysis on China's Ophthalmic Preparation Market
2.2 Analysis on China's Ophthalmic Preparation Market Shares
2.3 Analysis on Market Shares of Ophthalmic Preparation Manufacturers
2.4 Growth Rates of China's Major Ophthalmic Preparation Varieties, 2009-2010

3 Analysis on China's Major Ophthalmic Preparations, 2009-2010
3.1 Ofloxacin
3.2 Levofloxacin
3.3 Sodium Hyaluronate
3.4 Tobramycin/Dexamethasone
3.5 Tobramycin Sulfate
3.6 Basic Fibroblast Growth Factor
3.7 Pranoprofen
3.8 Difrarel

4 Analysis on China's Major Ophthalmic Preparation Manufacturers, 2010-2011
4.1 Hubei Qianjiang Pharmaceutical Co., Ltd.
4.2 Mentholatum (China) Pharmaceutical Co., Ltd.
4.3 Shandong Chia Tai Freda Pharmaceutical Co., Ltd.
4.4 Japan Santen Pharmaceutical Co., Ltd.
4.5 Jiangxi Tianshikang Traditional Chinese Medicine Co., Ltd.
4.6 Shandong Bausch & Lomb Freda Pharmaceutical Co., Ltd.
4.7 Traditional Chinese Medicine Factory of Hangzhou Tianmushan Pharmaceutical Enterprises Co., Ltd.
4.8 Fujian Shemingzhu Eye Drop Co., Ltd.
4.9 Shenyang Xingqi Pharmaceutical Co., Ltd.
4.10 Tianjin Wanjia Pharmaceutical Co., Ltd.
4.11 Hebei Jinniu Pharmaceutical Co., Ltd.
4.12 Changchun Dirui Pharmaceutical Co., Ltd.

5 Prediction on China's Ophthalmic Preparation Market Scale, 2011-2015
5.1 Analysis on Factors Influencing Development
5.2 Market Scale Prediction
5.3 Development Recommendations


List Of Figures

NA


List Of Tables


Chart China's Ophthalmic Preparation Market Scale, 2006-2010
Chart Changes in Market Shares of China's Major Ophthalmic Preparation Varieties, 2007-2009
Chart China's Ophthalmic Preparation Enterprises with Top 20 Market Shares, 2007-2009
Chart Ofloxacin Market Competition Pattern in China 
Chart Levofloxacin Market Competition Pattern in China
Chart Hyaluronate Sodium Market Competition Pattern in China
Chart Prediction on China's Ophthalmic Preparation Market Scale, 2011-2015

More Reports in





» Research Report on China's Anti-Prostatic Hyperplasia (PH) Drug Market, 2013-2017

Benign prostatic hyperplasia (BPH) is a common disease among middle-aged and elderly men, with an increasing morbidity as the rise in ages. Its invasion is possibly related to race and regions.  In China, the PH morbidity of men in urban regions is far higher than that in rural regions. The PH morbidity is influenced by severa...


» Research Report on China's Anti-Alzheimer's Disease (AD) Drug Market, 2013-2017

By the end of 2011, people aged 60 and above reached 185 million in China, accounting for 13.7% of the population, with an increase of 0.47 percentage point compared with that at the end of 2010. The elderly population in China will exceed 200 million by the end of 2013 and reach 221 million in 2015, accounting for 16% of the population, w...


» Research Report on China's Antidepressant Market, 2013-2017

Oct. 10 is "World Mental Health Day". In 2012, its theme is "Depression: a Global Crisis". According to statistics from the United Nations, about 350 million people suffer from depression in the world. Approximately one million people commit suicide every year because of depression. Depression becomes a health crisis worldwide. Depression ...


» Research Report on China's Antifungal Drug Market, 2013-2017

Fungi are usually opportunistic pathogens for healthy human bodies. Under conditions of weakened organism resistance and bad external factors, it is likely to cause general or local fungal infections. In recent years, fungal infection cases tend to gradually increase in China, which is related to following factors to a certain extent: ...


» Research Report on China's Diabetes Drug Market, 2013-2017

Diabetes refers to a series of metabolic disorder syndrome such as sugars, proteins, fat, water and electrolyte that are triggered by islet dysfunction and insulin resistance, and the latter is caused by the actions of various pathogenic factors such as genetic factors, immune disorders, microbial infections and their toxins, free radical t...


» Research Report on China's Automobile Spare Parts Industry, 2013-2017

In China, the automobile spare parts industry refers to the manufacture of motor vehicles and various accessories of their bodies. Automobile spare parts researched in this report mainly include engines, tires, automobile glass, automobile electronics, etc.  With 30 years of development since the reform and opening up, especia...


» Research Report on China's Power Generation Equipment Industry, 2013-2017

Supported by polices of the Chinese government, new energy and clean energy such as nuclear power, wind power and hydropower swiftly and violently develop in China, which drives the continuous increase in the output of generator sets. In 2011, the output of power generation equipment reached 147 million kilowatts nationwide.  ...


» Research Report on China's Urban Rail Transit Industry, 2013-2017

The development of urban rail transit solves the contradiction between distance and time for long-distance transport in working life. In addition, it improves the life quality of residents and promotes the formation of rational layout of cities. In China's history, the first urban rail transit was built in Nanjing in the 1930s, which was d...


» Research Report on China's High-end Medical Treatment Industry, 2013-2017

In recent years, the market size of China's medical services continuously expands, but whole medical services are on the rather low level. The rich and foreigners in China attach importance to quality and privacy of medical services and they are unwilling to accept the noisy and crowded hospital environment and inferior service attitudes o...


» Research Report on China's Antithrombotic Drug Market, 2013-2017

Thrombosis refers to the formation of local blood clots. Among it, artery thrombosis can cause myocardial infarction, stroke, acute coronary syndrome, peripheral arterial diseases, etc.; venous thrombosis can cause pulmonary embolism. Arteriovenous thrombosis is the primary reason for incidence and death of cardiovascular diseases, which i...



Related News

News Sep 18, 2012

Premiers of China and Kyrgyzstan Agree to Advance Agricultural Collaboration

The meet between Vice Premier of China Hui Liangyu and the Kyrgyz President Almazbek Atambayev has brought in food news for the agriculture industry. Both the countries have agreed to further boost mutual trade and industry cooperation, especiall...

News Sep 13, 2012

Chinese Solar Companies Gear-Up for EU Anti-Dumping Probe, Ask to End Protectionism

Reacting strongly towards the European Commission’s (EU) impending anti-dumping probe into Chinese solar panel imports, China has called the decision ‘regrettable’ and said that it will have negative effects on the trade relatio...

News Sep 11, 2012

Mendel Biotechnology Co and Bayer Develop Herbicide Resistance Breaking Technology

Mendel Biotechnology and Bayer CropScience have collaborated to jointly come up with a herbicide with novel modes of action. There is increasing evidence of weeds resistant to herbicides in different geographies, including those that are resistan...

News Aug 25, 2012

Global Health-Care Market

Global health-care spending, with its current rate of growth is expected to doubleby year 2020 and reach a market size worth USD 70.9 trillion, accountingfor almost 25-30 percent of Global GDP.The rise in spending is attributed to growth of healt...

News Aug 25, 2012

Global Hospital Investment Market

Hospital investment deals with the capital flows and investment trends in hospital construction market. Global healthcare investment market is segmented in two categories – Public hospital sectors and Private hospital sectors Contin...

News Aug 25, 2012

Global Medical Simulation Market

Medical simulation is a training method used to train different processes and tasks to medical professionalsin life like circumstances. Theprocess requires several tools or equipment which includes models, actor-patients, peers, surveillance and ...

News Aug 24, 2012

Chinese Solar Industry smacked by Weak Sales

The Solar industry in china is seeing a downturn after a robust growth in the last decade. The industry has suffered huge financial losses due to decrease in sales worldwide. Another reason for this downturn is the ongoing price war between other...

News Aug 24, 2012

China Paving Way for Jet Biofuels

Boeing and COMAC – Commercial Aircraft Corporation of China have established a new laboratory in Beijing which shall perform research upon creating a method of refining “gutter oil” – waste cooking oil and create jet fuel....

News Aug 24, 2012

Chinese Firm taps at Rockville Biotech for Vaccine Technology

A Chinese company is being tapped by the drug manufacturer Rockville Biotech Fina Solutions for vaccine technology. Rockville Biotech is licensing the firm to manufacture pneumonia vaccine by using its developed technology. Rockville Biot...

News Aug 24, 2012

Package Delivery Industry Set to Boom in China

Following the lead of the U.S. and Japan, China has evolved as the third largest package delivery market in the world. In the year 2011 more than 7,500 package delivery companies were operating in China. Every day, approximately 130 million packa...








All Rights Reserved   Latest News   Latest Reports